Literature DB >> 15256798

Regional citrate anticoagulation in critically ill patients treated with plasma filtration and adsorption.

Filippo Mariano1, Ciro Tetta, Maurizio Stella, Piera Biolino, Antonio Miletto, Giorgio Triolo.   

Abstract

BACKGROUND: In high-risk bleeding conditions conventional systemic anticoagulation with heparin is a contraindication to renal replacement therapy. We evaluate the feasibility and safety of regional citrate anticoagulation in high-risk bleeding conditions during coupled plasma filtration adsorption (CPFA).
METHODS: Thirteen critically ill patients (9 severely burned, 4 polytraumas) with septic shock and acute renal failure treated with CPFA-CVVHD by using bicarbonate-based solutions (heparin-CPFA group, 58 sessions) or with CPFA-CVVHF using citrate (citrate-CPFA group, 36 sessions).
RESULTS: Plasma flow and used cartridges showed no differences between the citrate-CPFA and heparin-CPFA groups, while lost clotted cartridges were significantly lower in the citrate-CPFA group. Blood ionized calcium (iCa2+), Ca2+ infusion, pH and bicarbonates remained constant during citrate-CPFA, with no difference between pre- and post-cartridge plasma citrate. A significant positive correlation between iCa2+ in blood and ultrafiltrate was present.
CONCLUSIONS: These suits demonstrate the feasibility and safety of regional citrate anticoagulation in severely burned and polytrauma septic patients treated by CPFA.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15256798     DOI: 10.1159/000078788

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  11 in total

Review 1.  Regional citrate anticoagulation for renal replacement therapies in patients with acute kidney injury: a position statement of the Work Group "Renal Replacement Therapies in Critically Ill Patients" of the Italian Society of Nephrology.

Authors:  Enrico Fiaccadori; Valentina Pistolesi; Filippo Mariano; Elena Mancini; Giorgio Canepari; Paola Inguaggiato; Marco Pozzato; Santo Morabito
Journal:  J Nephrol       Date:  2015-01-14       Impact factor: 3.902

2.  Efficient removal of colistin A and B in critically ill patients undergoing CVVHDF and sorbent technologies.

Authors:  Filippo Mariano; Marta Leporati; Paola Carignano; Maurizio Stella; Marco Vincenti; Luigi Biancone
Journal:  J Nephrol       Date:  2014-09-24       Impact factor: 3.902

3.  Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients.

Authors:  Filippo Mariano; Luisa Tedeschi; Maurizio Morselli; Maurizio Stella; Giorgio Triolo
Journal:  Intensive Care Med       Date:  2010-05-18       Impact factor: 17.440

4.  High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial.

Authors:  Elena Garbero; Sergio Livigni; Fiorenza Ferrari; Stefano Finazzi; Martin Langer; Paolo Malacarne; Manlio Cosimo Claudio Meca; Sabino Mosca; Carlo Olivieri; Marco Pozzato; Carlotta Rossi; Mario Tavola; Marina Terzitta; Bruno Viaggi; Guido Bertolini
Journal:  Intensive Care Med       Date:  2021-10-03       Impact factor: 17.440

5.  Citrate anticoagulation for continuous renal replacement therapy in critically ill patients: success and limits.

Authors:  Filippo Mariano; Daniela Bergamo; Ezio Nicola Gangemi; Zsuzsanna Hollo'; Maurizio Stella; Giorgio Triolo
Journal:  Int J Nephrol       Date:  2011-03-16

6.  Detoxification of bilirubin and bile acids with intermittent coupled plasmafiltration and adsorption in liver failure (HERCOLE study).

Authors:  Gabriele Donati; Andrea Angeletti; Lorenzo Gasperoni; Fabio Piscaglia; Anna Laura Croci Chiocchini; Anna Scrivo; Teresa Natali; Ines Ullo; Chiara Guglielmo; Patrizia Simoni; Rita Mancini; Luigi Bolondi; Gaetano La Manna
Journal:  J Nephrol       Date:  2020-07-24       Impact factor: 3.902

7.  Unravelling the enigma of proteinuria in burn patients.

Authors:  Filippo Mariano; Giovanni Camussi
Journal:  Crit Care       Date:  2012-12-05       Impact factor: 9.097

8.  Circulating plasma factors induce tubular and glomerular alterations in septic burns patients.

Authors:  Filippo Mariano; Vincenzo Cantaluppi; Maurizio Stella; Giuseppe Mauriello Romanazzi; Barbara Assenzio; Monica Cairo; Luigi Biancone; Giorgio Triolo; V Marco Ranieri; Giovanni Camussi
Journal:  Crit Care       Date:  2008-03-25       Impact factor: 9.097

9.  Efficacy of coupled plasma filtration adsorption (CPFA) in patients with septic shock: a multicenter randomised controlled clinical trial.

Authors:  Sergio Livigni; Guido Bertolini; Carlotta Rossi; Fiorenza Ferrari; Michele Giardino; Marco Pozzato; Giuseppe Remuzzi
Journal:  BMJ Open       Date:  2014-01-08       Impact factor: 2.692

Review 10.  Extracorporeal techniques for the treatment of critically ill patients with sepsis beyond conventional blood purification therapy: the promises and the pitfalls.

Authors:  Ghada Ankawi; Mauro Neri; Jingxiao Zhang; Andrea Breglia; Zaccaria Ricci; Claudio Ronco
Journal:  Crit Care       Date:  2018-10-25       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.